ABBV

AbbVie Inc.

Health Care · Biotechnology

$89.67 sample

+0.30 (+0.34%) 1D

Market cap

$244.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-07

Alerts

8

Price$89.67 +0.88% 3M daily closessample

96.4788.89

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07SEC10-Q filed
Sep 28SEC10-Q filed
Sep 23INSInsider sell: EVP, Operations
Sep 14INSInsider buy: Chief Executive Officer
Sep 08INSInsider sell: EVP, Operations
Aug 28INSInsider sell: Director
Aug 20INSInsider sell: Director
Aug 17INSInsider sell: 10% owner

Sign up to see the real ABBV record →

Company facts

SEC EDGAR registration

Name: AbbVie Inc.
Sector: Health Care
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in ABBV

sample

Insiders: 34 insider transactions over 90 days, net selling, $115.5M
Congress: 3 members traded over 90 days
Institutions · 13F: 40 funds hold $2.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$15.1B +18.8% y/y

Q4 2024Q3 2026

Inventory$9.1B +16.0% y/y

Q4 2024Q3 2026

Accounts receivable$6.7B +16.3% y/y

Q4 2024Q3 2026

Total debt$17.5B +14.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $236.7B -10.7% 3M
Sample peer B: $178.0B -8.8% 3M
Sample peer C: $106.5B +0.4% 3M
Sample peer D: $76.0B -8.1% 3M
Sample peer E: $152.0B +4.2% 3M